manufacture refraction instruments, ophthalmic diagnostic instruments, visual acuity chart, ophthalmic unit, electric table，One stop medical instrument
Currency:
USD
USD EUR GBP JPY AED AUD BRL CAD CHF DKK HKD IDR INR KRW MOP MYR NOK NZD PHP RUB SAR SEK THB TRY TWD SGD ZAR
Language:
English
English Deutsch Français Русский にほんご 한국어 Español Português Italiano العربية Nederlands Ελληνικά
Sign In or Join Free
English
English
Deutsch
Français
Русский
にほんご
한국어
Español
Português
Italiano
العربية
Nederlands
Ελληνικά
USD
USD
EUR
GBP
JPY
AED
AUD
BRL
CAD
CHF
DKK
HKD
IDR
INR
KRW
MOP
MYR
NOK
NZD
PHP
RUB
SAR
SEK
THB
TRY
TWD
SGD
ZAR
Search History
You May Also Like
Optical shop trial lens set, CE certified trial lens kit, Portable trial lens set for optometry Digital lensometer manufacturer, High precision auto focimeter, Optical shop lens power meter Ophthalmic Equipment, Vision Testing Device, Eye Refractometer Visual Acuity Projector, Eye Chart Projector, Vision Testing Projector Durable trial lens set with case, Anti-reflective coating trial lenses, Custom trial lens set OEM Hospital ophthalmic patient chair,Comfortable optometry examination chair,Custom optometry patient chair OEM Ophthalmoscope, Direct Ophthalmoscope, Indirect Ophthalmoscope Hospital ophthalmic vision testing device,High precision eye refractometer supplier,Custom optometry instrument OEM Hospital ophthalmic patient chair, Comfortable optometry examination chair, Custom optometry patient chair OEM
Home / Blogs /
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline
Home Blogs
Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline

November 02, 2019

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focused on the discovery, development, and commercialization of therapeutics for vascular diseases. It was founded in July 2012 and is led by President and CEO, Dr. George Nikopoulos. Q BioMed and Mannin have been partners since 2015.

WhatsApp